Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1992 Jun 20;304(6842):1593–1596. doi: 10.1136/bmj.304.6842.1593

Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

A Tyler 1, D Ball 1, D Craufurd 1
PMCID: PMC1881988  PMID: 1385747

Abstract

OBJECTIVE--To evaluate the United Kingdom Huntington's disease presymptomatic testing programme. DESIGN--Postal questionnaire survey to collect data on all tests performed by clinical genetics centres between 1987 and 1990. SETTING--Genetic centres providing presymptomatic testing in the United Kingdom. SUBJECTS--248 subjects at risk of Huntington's disease who had presymptomatic testing at their request. MAIN OUTCOME MEASURES--Sex, age, prior risk, and risk after testing. RESULTS--The risk of carrying the Huntington disease gene was reduced for 151 (61%) of the applicants and raised for 97 (39%). 158 (64%) of the subjects were female and 90 (36%) male. The median age at which the results were given was 32.5 years. CONCLUSIONS--The demand for testing was lower than expected and may have reached its peak in 1990. The excess of low risk results was not fully explained by the age effect. All the genetics centres concerned have agreed a common service protocol which requires extensive pre-test counselling and post-test follow up. The worth of the procedure remains to be decided. The availability of a large body of pooled data from all the United Kingdom testing centres, which individually are likely to have only a few results, will form a valuable resource for monitoring the long term psychosocial impact of testing.

Full text

PDF
1593

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandt J., Quaid K. A., Folstein S. E., Garber P., Maestri N. E., Abbott M. H., Slavney P. R., Franz M. L., Kasch L., Kazazian H. H., Jr Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. JAMA. 1989 Jun 2;261(21):3108–3114. [PubMed] [Google Scholar]
  2. Craufurd D. I., Harris R. Ethics of predictive testing for Huntington's chorea: the need for more information. Br Med J (Clin Res Ed) 1986 Jul 26;293(6541):249–251. doi: 10.1136/bmj.293.6541.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Craufurd D., Dodge A., Kerzin-Storrar L., Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 1989 Sep 9;2(8663):603–605. doi: 10.1016/s0140-6736(89)90722-8. [DOI] [PubMed] [Google Scholar]
  4. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  5. Harper P. S., Newcombe R. G. Age at onset and life table risks in genetic counselling for Huntington's disease. J Med Genet. 1992 Apr;29(4):239–242. doi: 10.1136/jmg.29.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hayden M. R., Robbins C., Allard D., Haines J., Fox S., Wasmuth J., Fahy M., Bloch M. Improved predictive testing for Huntington disease by using three linked DNA markers. Am J Hum Genet. 1988 Nov;43(5):689–694. [PMC free article] [PubMed] [Google Scholar]
  7. Lam R. W., Bloch M., Jones B. D., Marcus A. M., Fox S., Amman W., Hayden M. R. Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program. J Clin Psychiatry. 1988 Nov;49(11):444–447. [PubMed] [Google Scholar]
  8. Mastromauro C., Myers R. H., Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet. 1987 Feb;26(2):271–282. doi: 10.1002/ajmg.1320260205. [DOI] [PubMed] [Google Scholar]
  9. Meissen G. J., Myers R. H., Mastromauro C. A., Koroshetz W. J., Klinger K. W., Farrer L. A., Watkins P. A., Gusella J. F., Bird E. D., Martin J. B. Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med. 1988 Mar 3;318(9):535–542. doi: 10.1056/NEJM198803033180903. [DOI] [PubMed] [Google Scholar]
  10. Morris M., Tyler A., Harper P. S. Adoption and genetic prediction for Huntington's disease. Lancet. 1988 Nov 5;2(8619):1069–1070. doi: 10.1016/s0140-6736(88)90078-5. [DOI] [PubMed] [Google Scholar]
  11. Sandkuyl L., Ott J. Determining informativity of marker typing for genetic counseling in a pedigree. Hum Genet. 1989 May;82(2):159–162. doi: 10.1007/BF00284050. [DOI] [PubMed] [Google Scholar]
  12. Tyler A., Harper P. S. Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet. 1983 Jun;20(3):179–188. doi: 10.1136/jmg.20.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES